155 related articles for article (PubMed ID: 15526377)
1. NDRG2 expression and mutation in human liver and pancreatic cancers.
Hu XL; Liu XP; Lin SX; Deng YC; Liu N; Li X; Yao LB
World J Gastroenterol; 2004 Dec; 10(23):3518-21. PubMed ID: 15526377
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
3. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
4. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
[TBL] [Abstract][Full Text] [Related]
5. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma.
Yu GZ; Zhu MH; Zhu Z; Ni CR; Zheng JM; Li FM
World J Gastroenterol; 2004 Dec; 10(24):3597-601. PubMed ID: 15534913
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
8. Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.
Shi H; Jin H; Chu D; Wang W; Zhang J; Chen C; Xu C; Fan D; Yao L
Biol Pharm Bull; 2009 Jun; 32(6):968-75. PubMed ID: 19483300
[TBL] [Abstract][Full Text] [Related]
9. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
10. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
11. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma.
Jiang Y; Zhou XD; Liu YK; Wu X; Huang XW
World J Gastroenterol; 2002 Oct; 8(5):804-7. PubMed ID: 12378619
[TBL] [Abstract][Full Text] [Related]
12. Expression of NDRG2 in clear cell renal cell carcinoma.
Ma J; Jin H; Wang H; Yuan J; Bao T; Jiang X; Zhang W; Zhao H; Yao L
Biol Pharm Bull; 2008 Jul; 31(7):1316-20. PubMed ID: 18591767
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
[TBL] [Abstract][Full Text] [Related]
15. [Alterations in DPC4 gene in pancreatic cancers].
Gu L; Chen J; Cui Q
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
[TBL] [Abstract][Full Text] [Related]
16. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
Cui J; Zhou X; Liu Y; Tang Z
J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
[TBL] [Abstract][Full Text] [Related]
17. Role of the MEN1 tumour suppressor gene in human ductal pancreatic cancer.
Karges W; Maier S; Schmidt F; Gress TM; Boehm BO
Cancer Lett; 2000 Aug; 157(1):51-5. PubMed ID: 10893442
[TBL] [Abstract][Full Text] [Related]
18. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines.
Kaino M
J Gastroenterol; 1997 Feb; 32(1):40-6. PubMed ID: 9058294
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
